is semaglutide compound effective FDA Warns on Certain Forms of Compounded What You Need to Know

The April 30, 2026 FDA proposal would further close the 503B bulks pathway permanently

Clinical trial subgroup analyses consistently show that participants with a BMI of 35 or higher lose a larger percentage of body weight than those with lower BMIs

Over a 48-week trial in adults with obesity but no diabetes, the highest tested dose of 12 mg once weekly produced an average 24.2% reduction in body weight , compared with just over 2% in the placebo group

Current non-clinical and preclinical investigations continue to examine its potential role in metabolic pathways [1]

As with any prescription medication, tirzepatide may carry risks and side effects